STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Forte Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Please see note in Item 4(a)


SCHEDULE 13G




Comment for Type of Reporting Person: Please see note in Item 4(a)


SCHEDULE 13G



Boothbay Fund Management, LLC
Signature:Ari Glass
Name/Title:Ari Glass, Managing Member
Date:08/07/2025
Ari Glass
Signature:Ari Glass
Name/Title:Individually
Date:08/07/2025
Exhibit Information

Exhibit I - JOINT FILING STATEMENT

Forte Biosciences Inc

NASDAQ:FBRX

FBRX Rankings

FBRX Latest News

FBRX Latest SEC Filings

FBRX Stock Data

256.30M
10.71M
4.96%
85.47%
0.8%
Biotechnology
Pharmaceutical Preparations
Link
United States
DALLAS